Lucia Novak, director of Riverside Diabetes Center, discusses the benefits of long-acting insulins and barriers that may prevent more widespread implementation of these therapies.
Lucia Novak, director of Riverside Diabetes Center in Maryland, defines clinical inertia and outlines patient- and practitioner-level factors that may impede appropriate management of your patients’...
In this podcast, Sri Banerjee, MD, PhD, MPH, MAS, Anayra Tua-Lopez, PhD, MPH, and David Harvey, PhD, MPH, speak about the racial differences in the association between endocrine disruptors...
